Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling

Medical Mycology

Volumn 49, Issue 5, 2011, Pages 513-524

  Sheth, Chirag C ^a   Hall, Rebecca ^a   Lewis, Leanne ^a   Brown, Alistair J P ^a   Odds, Frank C ^a   Erwig, Lars P ^a   Gow, Neil A R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

C. albicans; glycosylation; innate immunity; PMN

Indexed keywords

INTERLEUKIN 8; MANNAN; MYELOPEROXIDASE;

ARTICLE; CANDIDA ALBICANS; CELL KILLING; CELL WALL; CONTROLLED STUDY; CYTOKINE RELEASE; FUNGAL STRAIN; FUNGUS CELL WALL; FUNGUS MUTANT; GLYCOSYLATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIGAND BINDING; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMORPHONUCLEAR CELL; YEAST CELL;

CANDIDA ALBICANS; CELL WALL; CYTOKINES; GLYCOSYLATION; HUMANS; MANNANS; MICROBIAL VIABILITY; NEUTROPHILS; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

CANDIDA ALBICANS;

EID: 79959212041     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.551425     Document Type: Article

References (60)

1. Bodey GP, Mardani M, Hanna HA, et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 2002; 112: 380-385. (Pubitemid 34248029)
2. Odds FC. Candida and Candidosis, 2nd edn. London, England: Baillière Tindall, 1988.
3. Pfaller MA, Messer SA, Houston A, et al. National epidemiology of mycoses survey: A multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 1998; 31: 289-296. (Pubitemid 28212057)
4. de Rosa FG, Garazzino S, Pasero D, di Perri G, Ranieri VM. Invasive candidiasis and candidemia: new guidelines. Minerva Anestesiol 2009; 75: 453-458.
5. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37: 1172-1177. (Pubitemid 37372504)
6. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med 2006; 34: 857-863.
7. Pfaller MA, Jones RN, Doern GV, Sader HS, and The SENTRY Participant Group. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000; 44: 747-751. (Pubitemid 30117972)
8. Prado M, d. Silva MB, Laurenti R, Travassos LR, Taborda CP. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem I Oswaldo Cruz 2009; 104: 513-521.
9. Lyman CA, Walsh TJ. Phagocytosis of medically important yeasts by polymorphonuclear leukocytes. Infect Immun 1994; 62: 1489-1493. (Pubitemid 24110851)
10. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000; 80: 617-653.
11. Netea MG, Brown GD, Kullberg BJ, Gow NAR. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008; 6: 67-78. (Pubitemid 350286221)
12. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449: 819-826. (Pubitemid 47598622)
13. Salih HR, Husfeld L, Adam D. Simultaneous cytofluorometric measurement of phagocytosis, burst production and killing of human phagocytes using Candida albicans and Staphylococcus aureus as target organisms. Clin Microbiol Infect 2000; 6: 251-258. (Pubitemid 36267429)
14. Maertens J, Vrebos M, Boogaerts M. Assessing risk factors for systemic fungal infections. Eur J Cancer Care 2001; 10: 56-62. (Pubitemid 33699410)
15. Martino P, Girmenia C, Venditti M, et al. Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 1989; 64: 2030-2034. (Pubitemid 19280400)
16. Hilal E-M, Fletcher J. Impaired neutrophil function and myeloperoxidase deficiency in myeloid metaplasia. Brit J Haematol 1977; 37: 323-329. (Pubitemid 8258693)
17. Lehrer RI, Cline MJ. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 1969; 48: 1478-1488.
18. Klis FM, De Groot P, Hellingwerf K. Molecular organization of the cell wall of Candida albicans. Med Mycol 2001; 39(Suppl. 1): 1-8.
19. Reid DM, Gow NAR, Brown GD. Pattern recognition: recent insights from dectin-1. Curr Opin Immunol 2009; 21: 30-37.
20. Dean N. Asparagine-linked glycosylation in the yeast golgi. BBA-Gen Subjects 1999; 1426: 309-322. (Pubitemid 29027947)
21. Lengeler K, Tielker D, Ernst J. Protein- O -mannosyltransferases in virulence and development. Cell Mol Life Sci 2008; 65: 528-544.
22. Strahl-Bolsinger S, Gentzsch M, Tanner W. Protein O-mannosylation. BBA-Gen Subjects 1999; 1426: 297-307. (Pubitemid 29027946)
23. Bates S, Hughes HB, Munro CA, et al. Outer chain N -glycans are required for cell wall integrity and virulence of Candida albicans. J Biol Chem 2006; 281: 90-98. (Pubitemid 43671166)
24. Hobson RP, Munro CA, Bates S, et al. Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition. J Biol Chem 2004; 279: 39628-39635. (Pubitemid 39258230)
25. Mora-Montes HM, Bates S, Netea MG, et al. Endoplasmic reticulum α-glycosidases of Candida albicans are required for N-glycosylation, cell wall integrity, and normal host-fungus interaction. Euk Cell 2007; 6: 2184-2193.
26. Munro CA, Bates S, Buurman ET, et al. Mnt1p and Mnt2p of Candida albicans are partially redundant α-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence. J Biol Chem 2005; 280: 1051-1060.
27. Cutler JE. N-glycosylation of yeast, with emphasis on Candida albicans. Med Mycol 2001; 39: 75-86.
28. Fradin C, Poulain D, Jouault T. Beta-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3. Infect Immun 2000; 68: 4391-4398. (Pubitemid 30497703)
29. Han Y, Kanbe T, Cherniak R, Cutler J. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect Immun 1997; 65: 4100-4107. (Pubitemid 27422065)
30. Masuoka J. Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev 2004; 17: 281-310. (Pubitemid 38534031)
31. Gow, NAR, Bates S, Brown AJP, et al. Candida cell wall mannosylation: importance in host-fungus interactions and potential as a target for the development of antifungal drugs. Biochem Soc Trans 1999; 27: 512-516. (Pubitemid 29412478)
32. Rouabhia M, Schaller M, Corbucci C, et al. Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases. Infect Immun 2005; 73: 4571-4580. (Pubitemid 41105611)
33. Timpel C, Strahl-Bolsinger S, Ziegelbauer K, Ernst JF. Multiple functions of Pmt1p-mediated protein O-mannosylation in the fungal pathogen Candida albicans. J Biol Chem 1998; 273: 20837-20846. (Pubitemid 28385362)
34. Timpel C, Zink S, Strahl-Bolsinger S, Schroppel K, Ernst J. Morphogenesis, adhesive properties, and antifungal resistance depend on the Pmt6 protein mannosyltransferase in the fungal pathogen Candida albicans. J Bacteriol 2000; 182: 3063-3071. (Pubitemid 30326919)
35. Corbucci, C., E. Cenci, F. Skrzypek, et al. Immune response to Candida albicans is preserved despite defect in O-mannosylation of secretory proteins. Med Mycol 2007; 45: 709-719. (Pubitemid 350153963)
36. McPhillips KA, Erwig LP. Assessment of apoptotic cell phagocytosis by macrophages. Methods Mol Biol 2009; 559: 2347-2356.
37. Hanks JH, Wallace JH. Determination of cell viability. Proc Soc Exp Biol Med 1958; 98: 188-192.
38. 2+-ATPase, is required for glycosylation and virulence. J Biol Chem 2005; 280: 23408-23415.
39. Hazen KC, Singleton DR, Masuoka J. Influence of outer region mannosylphosphorylation on N-glycan formation by Candida albicans : normal acid-stable N-glycan formation requires acid-labile mannosylphosphate addition. Glycobiology 2007; 17: 1052-1060. (Pubitemid 47553528)
40. Feld M, Shpacovitch VM, Ehrhardt C, et al. Agonists of proteinase-activated receptor-2 enhance IFN-γ-inducible effects on human monocytes: role in influenza A infection. J Immunol 2008; 180: 6903-6910.
41. Schade AE, Schieven GL, Townsend R, et al. Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. Blood 2008; 111: 1366-1377. (Pubitemid 351213423)
42. Aratani Y, Koyama H, Nyui S, et al. Severe impairment in early host defence against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999; 67: 1828-1836. (Pubitemid 29144403)
43. Lehrer RI, Cline MJ. Interaction of Candida albicans with human leukocytes and serum. J Bacteriol 1969; 98: 996-1004.
44. Fradin C, Mavor AL, Weindl G, et al. The early transcriptional response of human granulocytes to infection with Candida albicans is not essential for killing but reflects cellular communications. Infect Immun 2007; 75: 1493-1501. (Pubitemid 46385843)
45. Schaller M, Boeld U, Oberbauer S, et al. Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 2004; 150: 2807-2813. (Pubitemid 39317783)
46. Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 2008; 106: 523-529. (Pubitemid 351156678)
47. Leroy O, Gangneux J, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37: 1612-1618.
48. Betts R, Glasmacher A, Maertens J, et al. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients Cancer 2006; 106: 466-473. (Pubitemid 43100459)
49. Cohen MS, Isturiz RE, Malech HL, et al. Fungal infection in chronic granulomatous disease: the importance of the phagocyte in defence against fungi. Am J Med 1981; 71: 59-66. (Pubitemid 12254714)
50. McKenzie CGJ, Koser U, Bain JM, et al. Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect Immun 2010; 78: 1650-1658.
51. Gow NAR, Netea MG, Munro CA, et al. Recognition of Candida albicans β-glucan by dectin-1 induces cytokines and has non-redundant effects on the activation of innate immunity. J Infect Dis 2007; 196: 1565-1571.
52. Fradin C, Slomianny MS, Mille C., et al. β-1,2 oligomannose adhesin epitopes are widely distributed over the different families of Candida albicans cell wall mannoproteins and are associated through both N- and O-glycosylation processes. Infect Immun 2008, 76: 4509-4517.
53. Lavigne LM, Albina JE, Reichner JS. Beta-glucan is a fungal determinant for adhesion-dependent human neutrophil functions. J Immunol 2006; 177: 8667-8675. (Pubitemid 44893831)
54. Yamamura M, Valdimarsson H. Participation of C3 in intracellular killing of Candida albicans. Scand J Immunol 1977; 6: 591-594. (Pubitemid 8140803)
55. Taylor PR, Tsoni VS, Willment JA, et al. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat Immunol 2007; 8: 31-38. (Pubitemid 46242356)
56. Diamond RD, Krzesicki R. Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro. J Clin Invest 1978; 61: 360-369. (Pubitemid 8280406)
57. Tessarolli V, Gasparoto TH, Lima HR, et al. Absence of TLR2 influences survival of neutrophils after infection with Candida albicans. Med Mycol 2009; 25: 1-12
58. Ali A, Rautemaa R, Hietanen J, et al. Expression of interleukin-8 and its receptor IL-8RA in chronic hyperplastic candidosis. Oral Microbiol Immunol 2006; 21: 223-230. (Pubitemid 44336952)
59. Koziol-Montewka M, Magrys A, Paluch-Oles J, et al. MPO and cytokines in the serum of cancer patients in the context of Candida colonization and infection. Immunol Invest 2006; 35: 167-179.
60. Netea MG, Gow NAR, Munro CA, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and toll-like receptors. J Clin Invest 2006; 116: 1642-1650.